Drug
Apraclonidine clinical trials
- studies test it
- 5
- open now
- 1
- in phase 3
- 1
- first study started
- 2006
Keep track of what changes. Save the apraclonidine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2006 (1)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2020 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 1
- Phase 3
- 1
- Phase 4
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 4
Alcon Research (1) · American University of Beirut Medical Center (1) · Retina Consultants of Delmarva (1) · Walter Reed Army Medical Center (1) · University of Alabama at Birmingham (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses apraclonidine is read from its arms, and is right about nine times in ten.
Testing it · 5
- Iopidine to Decrease Intraocular Pressure Rise After InjectionsNot yet recruitingPhase 4Retina Consultants of DelmarvaNCT07891910Written as Apraclonidine 1.0% ophthalmic solution
- A Double-Masked Comparison of FID 123320 Ophthalmic Solution to Vehicle for the Reduction of Ocular RednessCompletedPhase 3Alcon ResearchNCT06444529Written as Apraclonidine Hydrochloride Ophthalmic Solution
- Efficacy of Topical Apraclonidine for the Treatment of Ocular SynkinesisWithdrawnPhase 4University of Alabama at BirminghamNCT05167760Written as Apraclonidine
- Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia GravisCompletedPhase 2American University of Beirut Medical CenterNCT05045248Written as Apraclonidine Hcl 0.5% Oph Soln
- Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser TrabeculoplastyStatus unknownNot applicableWalter Reed Army Medical CenterNCT00567411Written as Apraclonidine 0.5%
Codes
What other systems call apraclonidine · ClinicalTrials.gg INT002667
- MeSH (NLM) C016986apraclonidineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 843CEN85DIAPRACLONIDINEConfirmed FDA, NLM, Wikidata
- RxNorm 14845Confirmed FDA, Wikidata
- Wikidata Q4781812apraclonidineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61640ApraclonidineOne source FDA
- DrugBank DB00964One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C016986 | apraclonidine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 843CEN85DI | APRACLONIDINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 14845 | — | Confirmed FDA, Wikidata |
| Wikidata | Q4781812 | apraclonidine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61640 | Apraclonidine | One source FDA |
| DrugBank | DB00964 | — | One source Wikidata |
Also registered as apraclonidine hydrochloride (UNII D2VW67N38H · RxNorm 91350).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.